No Data
No Data
List of stock materials from newspapers including Sumitomo Corporation and Sony Group Corp.
*Sumitomo Shoji <8053> acquires a Romanian company and sells environmentally friendly fertilizers (Nikkan Kogyo front page) - ○ * Nippatsu <5991> comprehensively reform personnel system and promote human capital management (Nikkan Kogyo front page) -○ * NTT <9432> aims to raise performance and stock price by actively investing in growth businesses (Nikkan Kogyo page 3) -○ * SoftBank G <9984> negotiates with Korean company on revising investment in LINE Yahoo (Nikkan Kogyo page 3) - ○ * Denso <6902> apologizes for fuel pump problems and improves technology to prevent recurrence (Nikkan Kogyo
S&P 500, Nasdaq Retreat From Records as Nvidia Pulls Back | Wall Street Today
The S&P 500 and the Nasdaq retreated from record highs as Nvidia shares pulled back, accelerating declines for the semiconductor industry.
Johnson & Johnson Faces New Lawsuit(s) Related To Its Talc Products
Johnson & Johnson (NYSE:JNJ) is reportedly facing a new proposed class action lawsuit seeking damages and medical monitoring for women who have developed or may develop cancer due to using the company
S&P 500, Nasdaq 100 Dip From Record Highs As Investors Take Chipmaker Profits; Energy Sector Rebounds, Yields Rise: What's Driving Markets Thursday?
After the Juneteenth holiday break, Wall Street reopened with a cautious tone, as the S&P 500 and Nasdaq 100 indices declined after hitting all-time highs around midday trading in New York. This decli
Gilead Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/20/2024 15.56% Baird $80 → $80 Maintains Neutral 06/14/2024 6.89% RBC Capital $74 → $74 Reiterates Sect
Johnson & Johnson's Arthritis Drug Shows Potential In Crohn's Disease
Thursday, Johnson & Johnson (NYSE:JNJ) released topline data from the pivotal Phase 3 GRAVITI investigational study of Tremfya (guselkumab) subcutaneous (SC) induction therapy in adult patients with m